{"id":"activated-prothrombin-complex-concentrate","safety":{"commonSideEffects":[{"rate":"null","effect":"Hypersensitivity reactions"},{"rate":"null","effect":"Thromboembolic events"}]},"_chembl":{"chemblId":"CHEMBL2108764","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"It is used to treat bleeding episodes in patients with hemophilia A or B, and in patients with acquired hemophilia A. Activated Prothrombin Complex Concentrate contains a mixture of clotting factors that are necessary for blood to clot.","oneSentence":"Activated Prothrombin Complex Concentrate works by replacing clotting factors to help the blood to clot.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:18:52.671Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of bleeding episodes in patients with hemophilia A or B"},{"name":"Treatment of bleeding in patients with acquired hemophilia A"}]},"trialDetails":[{"nctId":"NCT06883240","phase":"","title":"An Observational Study of Participants With Type 3 Von Willebrand Disease on Prophylactic Standard-of-Care Treatment","status":"RECRUITING","sponsor":"Hoffmann-La Roche","startDate":"2025-04-29","conditions":"Von Willebrand Disease, Type 3","enrollment":40},{"nctId":"NCT04563520","phase":"PHASE3","title":"SAFE Study: Safety of aPCC Following Emicizumab Prophylaxis","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"Hemophilia A","enrollment":5},{"nctId":"NCT05156983","phase":"PHASE3","title":"A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery","status":"RECRUITING","sponsor":"Takeda","startDate":"2022-08-24","conditions":"Coagulation Disorder","enrollment":328},{"nctId":"NCT07290634","phase":"","title":"Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion","status":"RECRUITING","sponsor":"Zeliha Alicikus","startDate":"2026-01-30","conditions":"Thromboembolus, Massive Blood Transfusion; Thrombocytopenia, Trauma","enrollment":4},{"nctId":"NCT04023019","phase":"","title":"Treatment of Hemophilia A Patients With FVIII Inhibitors","status":"RECRUITING","sponsor":"Emory University","startDate":"2020-03-17","conditions":"Hemophilia A","enrollment":120},{"nctId":"NCT05281718","phase":"EARLY_PHASE1","title":"Factor IX as Adjunctive Therapy to Emicizumab (EMIX)","status":"COMPLETED","sponsor":"Tulane University","startDate":"2022-08-01","conditions":"Hemophilia A","enrollment":12},{"nctId":"NCT05010707","phase":"PHASE2","title":"Transgender Estradiol Affirming Therapy","status":"COMPLETED","sponsor":"Washington University School of Medicine","startDate":"2021-08-02","conditions":"Transgenderism","enrollment":39},{"nctId":"NCT02777424","phase":"PHASE4","title":"CPP Versus PFC to Correct Coagulation Disorders in Adult Neurosurgical Patients","status":"COMPLETED","sponsor":"Fondation Ophtalmologique Adolphe de Rothschild","startDate":"2016-01-21","conditions":"Intracranial Hemorrhages","enrollment":18},{"nctId":"NCT03921294","phase":"PHASE4","title":"HemLibra Prophylaxis in Patients With Hemophilic Pseudotumor","status":"TERMINATED","sponsor":"Indiana Hemophilia &Thrombosis Center, Inc.","startDate":"2019-05-15","conditions":"Haemophilic Pseudotumour","enrollment":1},{"nctId":"NCT04567511","phase":"PHASE4","title":"Hemlibra in Mild Hemophilia A","status":"RECRUITING","sponsor":"Indiana Hemophilia &Thrombosis Center, Inc.","startDate":"2022-07-25","conditions":"Factor VIII Deficiency, Congenital","enrollment":20},{"nctId":"NCT01561391","phase":"PHASE4","title":"Safety and Efficacy of Activated Recombinant Human Factor VII in Haemophilia Patients With Inhibitors During and After Major Surgery","status":"COMPLETED","sponsor":"Novo Nordisk A/S","startDate":"1998-04","conditions":"Congenital Bleeding Disorder, Haemophilia A With Inhibitors, Haemophilia B With Inhibitors","enrollment":36},{"nctId":"NCT02764489","phase":"PHASE3","title":"FEIBA Reconstitution Volume Reduction and Faster Infusion Study (FEIBA STAR)","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2019-02-12","conditions":"Hemophilia A or B With Inhibitors","enrollment":45},{"nctId":"NCT03809481","phase":"PHASE3","title":"Open-Label, Randomised, Active Controlled, Multi-Centre Phase 3 Study Safety and Efficacy of Danaparoid vs Argatroban","status":"TERMINATED","sponsor":"Aspen Global Incorporated","startDate":"2019-05-16","conditions":"Heparin-induced Thrombocytopenia","enrollment":7},{"nctId":"NCT05020483","phase":"PHASE2","title":"FEIBA to Optimize Postcardiopulmonary Bypass Hemostasis in Pediatric Cardiac Patients","status":"WITHDRAWN","sponsor":"Mayo Clinic","startDate":"2021-10","conditions":"Cardiac Disease","enrollment":""},{"nctId":"NCT02557672","phase":"PHASE4","title":"PCC vs. FFP for Post Cardiopulmonary Bypass Coagulopathy and Bleeding","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2016-08","conditions":"Bleeding, Blood Loss, Surgical, Cardiovascular Surgical Procedures","enrollment":106},{"nctId":"NCT03784794","phase":"NA","title":"Patient Blood Management for Massive Obstetric Hemorrhage","status":"COMPLETED","sponsor":"Angel Augusto Perez Calatayud","startDate":"2018-11-01","conditions":"Post Partum Hemorrhage, Fibrinogenolysis; Hemorrhage, Fibrinogen; Deficiency, Acquired","enrollment":100},{"nctId":"NCT01757405","phase":"PHASE3","title":"Recombinant Factor VIIa BI (rFVIIa BI) Treatment of Acute Bleeding Episodes Per an On-demand Regimen","status":"COMPLETED","sponsor":"Baxalta now part of Shire","startDate":"2013-02-20","conditions":"Hemophilia A, Hemophilia B","enrollment":40},{"nctId":"NCT00221195","phase":"PHASE2, PHASE3","title":"Efficacy Study of Activated Prothrombin Complex for Prevention of Bleeds in Hemophilia A With Inhibitors","status":"COMPLETED","sponsor":"Tulane University School of Medicine","startDate":"2003-06","conditions":"Hemophilia A With Inhibitors","enrollment":34},{"nctId":"NCT02565836","phase":"","title":"Fixed-dose Activated Versus Variable-dose Inactivated Prothrombin Complex Concentrate for Warfarin-associated Major Bleed","status":"COMPLETED","sponsor":"Rush University Medical Center","startDate":"2015-10","conditions":"Hemorrhage","enrollment":342},{"nctId":"NCT02429453","phase":"NA","title":"FFP Versus PCC in Intracranial Hemorrhage","status":"WITHDRAWN","sponsor":"University of Utah","startDate":"2015-04","conditions":"Intracranial Hemorrhage, Traumatic, Intracranial Hemorrhage, Spontaneous","enrollment":""},{"nctId":"NCT01352143","phase":"","title":"Thrombin Generation in Neonatal Plasma After Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Emory University","startDate":"2011-03","conditions":"Cardiopulmonary Bypass","enrollment":24},{"nctId":"NCT00770718","phase":"PHASE1","title":"Factor VII, Prothrombin Complex Concentrate, and Fresh Frozen Plasma in Warfarin-Related Intracranial Hemorrhage","status":"TERMINATED","sponsor":"University of Utah","startDate":"2008-04","conditions":"Intracranial Hemorrhage","enrollment":2}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":349,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_2","status":"active","brandName":"Activated Prothrombin Complex Concentrate","genericName":"Activated Prothrombin Complex Concentrate","companyName":"Hoffmann-La Roche","companyId":"hoffmann-la-roche","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Activated Prothrombin Complex Concentrate works by replacing clotting factors to help the blood to clot. Used for Treatment of bleeding episodes in patients with hemophilia A or B, Treatment of bleeding in patients with acquired hemophilia A.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}